Alcon AG vs TORM plc — how do they compare? Alcon AG trades at $72.57 (market cap $36.44B), while TORM plc trades at $28.33 (market cap $2.93B). The key difference: Alcon AG is far larger — about 12.4× TORM plc's market cap, and TORM plc pays the higher dividend (9.77%). Which is the better fit depends on your goals.
| ALC | TRMD | |
|---|---|---|
Market Cap | $36.44B | $2.93B |
Sector | Health | Technology |
52-Week High | $90.12 | $34.87 |
52-Week Low | $62.02 | $18.77 |
Enterprise Value | $40.28B | $3.82B |
Dividend Yield | 0.48% | 9.77% |
Trailing returns across standard periods
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →TORM plc is one of the world's largest owners and operators of product tankers, specializing in the transportation of refined oil products like gasoline, jet fuel, and diesel. Operating under its integrated 'One TORM' model, the company maintains a modern, wholly-owned fleet of nearly 90 vessels. It is widely recognized by investors for its aggressive variable dividend policy, which returns a significant portion of its cash flow directly to shareholders during periods of high freight rates.
Read more on TRMD →